Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP

Methods in Molecular Biology

Volumn 795, Issue , 2012, Pages 119-134

  Duncan, James S ^a,b   Haystead, Timothy A J ^c   Litchfield, David W ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

2D Gel electrophoresis; ATP sepharose; Chemoproteomics; Mass spectrometry; Protein kinase CK2; Protein kinase inhibitors

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATP SEPHAROSE; ATP-SEPHAROSE; CASEIN KINASE II; DRUG DERIVATIVE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; SEPHAROSE;

ARTICLE; BINDING COMPETITION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ASSAY; HELA CELL; HUMAN; METABOLISM; METHODOLOGY; PROTEIN BINDING; PROTEOMICS; REPRODUCIBILITY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; BINDING, COMPETITIVE; CASEIN KINASE II; CELL LINE, TUMOR; ENZYME ASSAYS; HELA CELLS; HUMANS; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SEPHAROSE;

EUKARYOTA;

EID: 80555135985     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-337-0_8     Document Type: Article

References (30)

1. Noble M.E., Endicott J.A., and Johnson L.N. (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303, 1800-1805. (Pubitemid 38374863)
2. Cohen P. (2002) Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309-315. (Pubitemid 37361447)
3. Sawyers C.L. (2003) Opportunities and challenges in the development of kinase inhibitor therapy for cancer. Genes Dev. 17, 2998-3010. (Pubitemid 38040763)
4. Lydon N.B., and Druker B.J. (2004) Lessons learned from the development of imatinib. Leuk. Res. 28, S29-38. (Pubitemid 38251496)
5. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934. (Pubitemid 35425239)
6. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., and Cohen P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315.
7. Bain J., McLauchlan H., Elliott M., and Cohen P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199-204. (Pubitemid 36458094)
8. Davies S.P., Reddy H., Caivano M., and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
9. Pagano M.A., Bain J., Kazimierczuk Z., Sarno S., Ruzzene M., Di Maira G., Elliott M., Orzeszko A., Cozza G., Meggio F., and Pinna L.A. (2008) The selectivity of inhibitors of protein kinase CK2: an update. Biochem. J. 415, 353-365.
10. Graves P.R., Kwiek J.J., Fadden P., Ray R., Hardeman K., Coley A.M., Foley M., and Haystead T.A. (2002) Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol. Pharmacol. 62, 1364-1372. (Pubitemid 35403831)
11. Haystead T.A. (2006) The purinome, a complex mix of drug and toxicity targets. Curr. Top. Med. Chem. 6, 1117-1127. (Pubitemid 44110924)
12. Duncan J.S., Gyenis L., Lenehan J., Bretner M., Graves L.M., Haystead T.A., and Litchfield D.W. (2008) An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Mol. Cell Proteomics 7, 1077-1088. (Pubitemid 351943955)
13. Landesman-Bollag E., Romieu-Mourez R., Song D.H., Sonenshein G.E., Cardiff R.D., and Seldin D.C. (2001) Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20, 3247-3257. (Pubitemid 32553677)
14. Litchfield D.W. (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15. (Pubitemid 36174119)
15. Duncan J.S., and Litchfield D.W. (2008) Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 1784, 33-47.
16. Sarno S., and Pinna L.A. (2008) Protein kinase CK2 as a druggable target. Mol. Biosyst. 4, 889-894.
17. Sarno S., Reddy H., Meggio F., Ruzzene M., Davies S.P., Donella-Deana A., Shugar D., and Pinna L.A. (2001) Selectivity of 4,5,6,7- tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett. 496, 44-48. (Pubitemid 32436419)
18. Zien P., Duncan J.S., Skierski J., Bretner M., Litchfield D.W., and Shugar D. (2005) Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2. Biochim. Biophys. Acta 1754, 271-280. (Pubitemid 41797708)
19. Pagano M.A., Meggio F., Ruzzene M., Andrzejewska M., Kazimierczuk Z., Pinna L.A. (2004) 2-Dimethylamino-4,5,6,7-tetrabromo-1-H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. Biochem. Biophys. Res. Commun. 321, 1040-1044. (Pubitemid 39044414)
20. Haystead C.M., Gregory P., Sturgill T.W., and Haystead T.A. (1993) Gamma-phosphatelinked ATP-sepharose for the affinity purification of protein kinases. Rapid purification to homogeneity of skeletal muscle mitogenactivated protein kinase kinase. Eur. J. Biochem. 214, 459-467. (Pubitemid 23173796)
21. Gietz R.D., Graham K.C., and Litchfield D.W. (1995) Interactions between the subunits of casein kinase II. J. Biol. Chem. 270, 13017-13021.
22. Battistutta R., De Moliner E., Sarno S., Zanotti G., and Pinna L.A. (2001) Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole. Protein Sci. 10, 2200-2206. (Pubitemid 32988637)
23. Sarno S., de Moliner E., Ruzzene M., Pagano M.A, Battistutta R., Bain J., Fabbro D., Schoepfer J., Elliott M., Furet P., Meggio F., Zanotti G., Pinna L.A. (2003) Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin- 7-yl] acetic acid (IQA). Biochem. J. 374, 639-646. (Pubitemid 37163909)
24. Graham K.C., and Litchfield D.W. (2000) The regulatory beta subunit of protein kinase CK2 mediates formation of tetrameric CK2 complexes. J. Biol. Chem. 275, 5003-5010. (Pubitemid 30108897)
25. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85. (Pubitemid 16258399)
26. Bradford M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
27. Towbin H., Staehelin T., and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76, 4350-4354. (Pubitemid 9256559)
28. Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
29. Görg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., and Weiss W. (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037-1053. (Pubitemid 30230771)
30. Görg A., Drews O., Lück C., Weiland F., and Weiss W. (2009) 2-DE with IPGs. Electrophoresis 30, S122-132.